news

Shearman & Sterling has advised Abu Dhabi's sovereign wealth fund Mubadala Investment on its acquisition of a majority stake in U.S. asset manager Fortress Investment Group from Japan's SoftBank Group, which turned to Morrison Foerster for counsel. Kirkland & Ellis represented Fortress.

Details of the deal have not been disclosed, but its value is estimated to be about $3 billion, according to Nikkei.

SoftBank, which acquired Fortress in 2017 for $3.3 billion, had been offloading assets to shore up its balance sheet as the value of its tech portfolio falters, Reuters reported.

The Shearman team included partners Clare O’Brien, Sean Skiffingston, John J. Cannon, Larry Crouch, Lorenz Haselberger, John Adams, Phil Baynes, Thomas Donegan, Jennifer D. Morton, Mark Chorazak, Michael Steinberg, Paula Howell Anderson, Jefferey J. Resetarits, and Tobia Croff.

The Kirkland team consisted of partners Daniel Lavon-Krein, Christopher Gandia, Carlo Zenkner, Mark Schwed, Florence Zhang, Christopher Urruela Stauss, Scott Price, Sally Ye, Jocelyn Hirsch, Thomas Dobleman, and Josh Korff.

Meanwhile, the MoFo team was led by partners Ken Siegel, Lauren Bellerjeau, and Patrick Barrett.

TO CONTACT EDITORIAL TEAM, PLEASE EMAIL ALBEDITOR@THOMSONREUTERS.COM

Related Articles

A&O Shearman advises Allianz on $1.6 bln Singapore insurance deal

by Nimitt Dixit |

A&O Shearman has advised German insurer Allianz on the acquisition of a 51 percent stake in Singapore's Income Insurance for S$2.2 billion ($1.6 billion), the latest major deal in Singapore’s buzzing insurance sector.

INDIA REPORT: Merger Momentum

by Nimitt Dixit |

Despite global uncertainties, India's M&A landscape remains robust, with domestic deals driving growth and diverse sectors attracting investments. Experts predict a positive outlook for H2 2024, bolstered by policy continuity and abundant dry powder.

Simpson Thacher, Nishimura act on Blackstone’s $2.17 bln Japan pharma sale

by Nimitt Dixit |

Japanese law firm Nishimura & Asahi has represented private equity group MBK Partners on its acquisition of drugmaker Alinamin Pharmaceuticals for 350 billion yen ($2.17 billion) from PE giant Blackstone, which was advised by its longstanding firm Simpson Thacher & Bartlett.